19th ISAM Annual Conference
Addiction Medicine: New Frontier

26-29 October, 2017 Abu Dhabi,UAE


Under the Patronage of

H.H. Sheikh Mansour bin Zayed Al Nahyan

Deputy Prime Minister and Minister of Presidential Affairs of the UAE

26 October - 29 October 2017
Emirates Palace, Abu Dhabi, UAE
Days Left
  • 00days
  • :
  • 00hours
  • :
  • 00minutes
  • :
  • 00seconds

About ISAM

About the Conference

Why Attend

Share and learn knowledge

Wonderful culture , fun, and weather for all

Enjoy the great Arabian Hospitality and Middle Eastern food

Meet old friends and make new memories


Who Attends

Addiction & General Psychiatry Clinicians and Counsellors

Primary care Doctors and Internists

Teachers and Law enforcement staff

Industry Representatives

Pharmacists & Medical Professionals


Conference Overview

Pre-conference Workshops:
25 October, 2017

Conference Opening:
25 October, 2017

Plenary Sessions, Symposiums, Meet the Expert Panels:
25 - 29 October, 2017

Public Forum
29 October, 2017


Plenary Speakers

Conference President, Director General NRC

speaker image H.E. Hamad Al Ghaferi, MBBS, MPH, PhD
on 26.10.2017

H.E. Hamad is the Director General of the National Rehabilitation Centre, Abu Dhabi, UAE Since September 2008. He receives his Bachelor of Medicine, Bachelor of Surgery (MBBS) from Faculty of Medicine, Jordan University of Science and Technology, Irbid, Kingdom Hashemite of Jordan, June 1999. He had his Master of Public Health (MPH)

View All

Coordinator, Management of Substance Abuse Department of Mental Health and Substance Abuse World Health Organization

speaker image Vladimir Poznyak
on 27.10.2017


View All

Head of Addiction Department King's College London

speaker image Sir John Strang
on 28.10.2017


View All

Professor of Psychiatry UAE University

speaker image Rafia Ghubash

Prof. RafiaGhubash is the first qualified psychiatrist in the UAE . She had a successful career in psychiatry including the accomplishment of conducting pioneering epidemiological research on the sociocultural risk factors for psychiatric disorders in the UAE community and attained the PhD at University of London. She conducted other studies in applied mental health research and published 45 papers in international peer-reviewed journals.

View All

Director, National Hospital Organization Kurihama Medical and Addiction Center

speaker image Susumu Higuchi, M.D., Ph.D.


View All

Section Director for Mental Health Policy,
Professor & Section Director for Mental Health Policy, Department of Psychiatry & Behavioral Sciences, Stanford University

speaker image Keith Humphreys
on 26.10.2017

Professor & Section Director for Mental Health Policy, Department of Psychiatry & Behavioral Sciences, Stanford University. Senior Research Career Scientist, VA Health Services Research Center, Palo Alta. Honorary Professor of Psychiatry, Institute of Psychiatry, Kings College London

View All

Chairman of the Board Treatment Research Institute

speaker image Thomas McLellan
on 28.10.2017


View All

Distinguished University Professor Vice President for Research Medical University of South Carolina

speaker image Kathleen T. Brady, MD, PhD

Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 30 years.

View All

Adjunct Professor
University of Maryland School of Medicine

speaker image Marilyn Huestis, MD

View All

Clinical Associate Professor of Family Medicine
University of Rochester
School of Medicine

speaker image Norman Wetterau, MD

Dr. Norman Wetterau represented ISAM and ASAM at UNGASS 2016. He is a clinical Associate Professor of Family Medicine at the University of Rochester School of Medicine, was visiting professor for Mental Health and Addiction at Hope Africa Medical School, Burundi for 6 years and is an Adjutant Professor at Northeastern Seminary in the Masters program on Theology and Social Justice. He practices family and addiction medicine in upstate New York. He is a previous board member of ASAM.

View All

M.P.H., M.D.
Acting Director of the Division of Therapeutics
and Medical Consequences of NIDA.

speaker image Dr. Ivan Montoya, MD

Dr. Montoya is the Acting Director of the Division of Therapeutics and Medical Consequences (DTMC) of the National Institute on Drug Abuse (NIDA). He received his M.D. from the University of Antioquia (Colombia), completed residency training in Psychiatry at the University of Antioquia and the University of Maryland Hospital (Baltimore), and a Master of Public Health at The Johns Hopkins School of Public Health. He was a Fulbright Fellow at The Johns Hopkins School of Public Health, Visiting Foreign Fellow at the Intramural Research Program of NIDA, Consultant for the Pan American Health Organization, and Director of the Practice Research Network of the American Psychiatric Association. He has published extensively in the areas of etiology, prevention, treatment (pharmacological and non-pharmacological), and medical consequences of drug abuse. He recently was the editor of a book summarizing the science on biologics (vaccines, monoclonal antibodies, and enzymes) to treat substance use disorders.

View All

Past Presiden WPA
Director of WHO Collaborating Center for Training & Research
Founder & Emeritus Professor - Ain Shams University

speaker image Ahmed Okasha
on 28.10.2017


View All

Professor of Psychiatry

speaker image Afarin Rahimi-Movaghar, MD, MPH

View All


speaker image Desiree A. Bruce-Lyle

View All



Conference Highlights

Destination & Cultural Partner

Co Sponsors

Platinum Sponsors

Silver Sponsor

Bronze Sponsor

Supporting Associations

Main Media Partner

Media Partners